Consensus DexCom, Inc. Mexican S.E.

Stocks

DXCM *

US2521311074

Medical Equipment, Supplies & Distribution

End-of-day quote Mexican S.E. 21/08/2026			5-day change	1st Jan Change
1,529.00 ^MXN	-0.57%		-.--%	+26.05%

25/08	Dexcom Insider Sold Shares Worth $2,408,242, According to a Recent SEC Filing	MT
13/08	Citigroup Adjusts Price Target on DexCom to $105 From $88, Maintains Buy Rating	MT

391688bc6ddb.y5rKVJLiV5AdzS4dIulAPrwWaRkggOnIi0VTwMZeEsQ._beuMdiuZfduh3l7Q5AEc9VTGH5myauwwnJiiPVvc5Wsw6Fj1pQ_0l_-Fg~066c5984a9eee24af13bc495194d96aa

Analysts' recommendations: DexCom, Inc.

13/08	Citigroup Adjusts Price Target on DexCom to $105 From $88, Maintains Buy Rating	MT
04/08	Argus Adjusts Price Target on DexCom to $96 From $86, Maintains Buy Rating	MT
03/08	UBS Adjusts Price Target on DexCom to $102 From $96, Maintains Buy Rating	MT
03/08	Rothschild & Co Redburn Adjusts Price Target on DexCom to $100 From $90, Maintains Buy Rating	MT
31/07	DexCom Glucose Monitors' National Coverage Could Support H2 Upside, RBC Capital Markets Says	MT
31/07	Leerink Partners Adjusts Price Target on DexCom to $94 From $80, Maintains Outperform Rating	MT
31/07	RBC Raises Price Target on DexCom to $90 From $85, Keeps Outperform Rating	MT
31/07	Canaccord Genuity Adjusts Price Target on DexCom to $90 From $82, Maintains Buy Rating	MT
31/07	Evercore ISI Adjusts Price Target on DexCom to $100 From $90, Maintains Outperform Rating	MT
31/07	Mizuho Adjusts Price Target on DexCom to $95 From $90, Maintains Outperform Rating	MT
31/07	Benchmark Adjusts Price Target on DexCom to $82 From $77, Maintains Buy Rating	MT
31/07	Bernstein Adjusts Price Target on DexCom to $90 From $77, Maintains Outperform Rating	MT
31/07	Deutsche Bank Adjusts DexCom Price Target to $92 From $86, Maintains Buy Rating	MT
31/07	Truist Raises Price Target on DexCom to $93 From $87, Keeps Buy Rating	MT
31/07	Baird Adjusts Price Target on DexCom to $105 From $80, Maintains Outperform Rating	MT
31/07	JPMorgan Adjusts Price Target on DexCom to $82 From $65, Maintains Neutral Rating	MT
31/07	Piper Sandler Adjusts Price Target on DexCom to $95 From $88, Maintains Overweight Rating	MT
31/07	Wells Fargo Adjusts Price Target on DexCom to $90 From $85, Maintains Overweight Rating	MT
31/07	Stifel Adjusts Price Target on DexCom to $95 From $90, Maintains Buy Rating	MT
31/07	Citigroup Adjusts Price Target on DexCom to $88 From $84, Maintains Buy Rating	MT
31/07	Jefferies Adjusts Price Target on DexCom to $115 From $112, Maintains Buy Rating	MT
31/07	BTIG Adjusts Price Target on DexCom to $90 From $80, Maintains Buy Rating	MT
31/07	Raymond James Adjusts Price Target on DexCom to $94 From $91, Maintains Strong Buy Rating	MT
31/07	Analyst recommendations: Apple, Baxter International, Dexcom, Flex, Humana, Stellantis…
28/07	UBS Adjusts Price Target on DexCom to $96 From $95, Maintains Buy Rating	MT

More recommendations

Other Medical Equipment, Supplies & Distribution

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ABBOTT LABORATORIES					+10.96%
	MEDTRONIC PLC					+11.25%
	CENCORA, INC.					+11.59%
	HOYA CORPORATION					+27.04%
	BECTON, DICKINSON AND COMPANY					+5.91%
	DEXCOM, INC.					+7.08%
	MEDLINE INC.					+21.89%
	WEST PHARMACEUTICAL SERVICES, INC.					+19.05%
	TERUMO CORPORATION					+29.14%
	Average					+15.99%
	Weighted average by Cap.					+13.50%